155 related articles for article (PubMed ID: 20423150)
1. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.
Makridakis M; Gagos S; Petrolekas A; Roubelakis MG; Bitsika V; Stravodimos K; Pavlakis K; Anagnou NP; Coleman J; Vlahou A
Proteomics; 2009 Jan; 9(2):287-98. PubMed ID: 19105184
[TBL] [Abstract][Full Text] [Related]
3. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma.
Mlynarek AM; Balys RL; Su J; Hier MP; Black MJ; Alaoui-Jamali MA
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):910-8. PubMed ID: 17875858
[TBL] [Abstract][Full Text] [Related]
4. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
5. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Perera CN; Spalding HS; Mohammed SI; Camarillo IG
Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
[TBL] [Abstract][Full Text] [Related]
6. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.
Kawanishi H; Matsui Y; Ito M; Watanabe J; Takahashi T; Nishizawa K; Nishiyama H; Kamoto T; Mikami Y; Tanaka Y; Jung G; Akiyama H; Nobumasa H; Guilford P; Reeve A; Okuno Y; Tsujimoto G; Nakamura E; Ogawa O
Clin Cancer Res; 2008 May; 14(9):2579-87. PubMed ID: 18451219
[TBL] [Abstract][Full Text] [Related]
7. Searching cell-secreted proteomes for potential urinary bladder tumor markers.
Lin CY; Tsui KH; Yu CC; Yeh CW; Chang PL; Yung BY
Proteomics; 2006 Aug; 6(15):4381-9. PubMed ID: 16819731
[TBL] [Abstract][Full Text] [Related]
8. The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells.
Chenau J; Michelland S; de Fraipont F; Josserand V; Coll JL; Favrot MC; Seve M
J Proteome Res; 2009 Oct; 8(10):4579-91. PubMed ID: 19639960
[TBL] [Abstract][Full Text] [Related]
9. Identification of annexin II as a novel secretory biomarker for breast cancer.
Jeon YR; Kim SY; Lee EJ; Kim YN; Noh DY; Park SY; Moon A
Proteomics; 2013 Nov; 13(21):3145-56. PubMed ID: 24019232
[TBL] [Abstract][Full Text] [Related]
10. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract][Full Text] [Related]
11. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer.
Volmer MW; Stühler K; Zapatka M; Schöneck A; Klein-Scory S; Schmiegel W; Meyer HE; Schwarte-Waldhoff I
Proteomics; 2005 Jul; 5(10):2587-601. PubMed ID: 15912508
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells.
Sosa MS; Girotti MR; Salvatierra E; Prada F; de Olmo JA; Gallango SJ; Albar JP; Podhajcer OL; Llera AS
Proteomics; 2007 Nov; 7(22):4123-34. PubMed ID: 17994631
[TBL] [Abstract][Full Text] [Related]
13. Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.
Dowling P; Maurya P; Meleady P; Glynn SA; Dowd AJ; Henry M; Clynes M
Anticancer Res; 2007; 27(3A):1309-17. PubMed ID: 17593624
[TBL] [Abstract][Full Text] [Related]
14. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of secreted proteins of non-small cell lung cancer.
Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H
Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902
[TBL] [Abstract][Full Text] [Related]
16. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis.
Tolson JP; Flad T; Gnau V; Dihazi H; Hennenlotter J; Beck A; Mueller GA; Kuczyk M; Mueller CA
Proteomics; 2006 Jan; 6(2):697-708. PubMed ID: 16252305
[TBL] [Abstract][Full Text] [Related]
17. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
19. Proteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MS.
Kang JH; Park KK; Lee IS; Magae J; Ando K; Kim CH; Chang YC
J Proteome Res; 2006 Oct; 5(10):2620-31. PubMed ID: 17022633
[TBL] [Abstract][Full Text] [Related]
20. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.
Saito M; Kimoto M; Araki T; Shimada Y; Fujii R; Oofusa K; Hide M; Usui T; Yoshizato K
Eur Urol; 2005 Nov; 48(5):865-71. PubMed ID: 15964125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
